What Is IceCure Medical Ltd. (ICCM) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, IceCure Medical Ltd.'s intrinsic value is estimated at a composite fair value of $2.01. Trading at $3.54, the stock is approaching fair value or slight overvaluation (implied return of -43.2%), as 8 of 11 models suggest limited further upside. Model dispersion is worth noting: PWERM targets $5.32 (+50.4%), versus EPV at $0.06 (-98.4%). This +148.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ICCM?
11 of 13 models are currently active for ICCM. Of these, 3 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates ICCM's intrinsic value at $1.12, implying -68.3% downside from the current price. See which stocks rank higher →
How Does ICCM Rank in Surgical & Medical Instruments & Apparatus?
Among 111 Surgical & Medical Instruments & Apparatus stocks, ICCM ranks #106 by Quality of Company score. CirclFi's QOC score of 2.7/10 evaluates 32 fundamental signals. A score of 2.7 signals below-average fundamentals.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
IceCure Medical Ltd. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is ICCM a Value Trap?
CirclFi's Value Trap algorithm assigns ICCM a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for IceCure Medical Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, IceCure Medical Ltd. earns a quality score of 2.7/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +148.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ICCM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ICCM's 11 active models, average confidence is 13%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad